Russell Osborne

Chief Technology Officer at Affect Therapeutics

Russell Osborne is currently working as the Chief Technology Officer at Affect Therapeutics, a company focused on changing the treatment of stimulant addiction. Russell has been in this role since February 2021. Prior to this, they were the Founder of Feldfix, an online marketplace connecting farmers and customers, from April 2014 to January 2016. Before that, they worked as a Director of Engineering and Senior Lead Software Engineer at Framebridge from October 2017 to January 2021. Russell also has experience as a Software Architect at Burningpony, where they built database-driven web applications for various industries from July 2009. Additionally, they worked as a Network Administrator at SciLucent, LLC from December 2005 to June 2015, and as an Account Manager at 20-20 Powervision, where they sold Verizon FIOS services from September 2007 to March 2008. Russell also owned a business called Small Business Computing Concepts, where they provided technical support and developed websites from April 2006 to July 2007. Before entering the tech industry, they worked as a Backend Engineering Instructor at The Iron Yard Academy from January 2016 to October 2017.

Russell Osborne obtained a Bachelor of Science (BS) degree in Biology from George Mason University. Russell attended the university from 2006 to 2010.

Links

Previous companies

Framebridge logo

Timeline

  • Chief Technology Officer

    February, 2021 - present